Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
← catalyst calendarNCT04779918 · readout in 223 d
Sponsored by Tela Bio Inc (industry) · TELA — their whole pipeline →. With MCRA.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
160estimated
Sites
10
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-04-29 | actual | When the study began enrolling |
| Primary completion | 2027-03-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2029-12-30 | estimated | The whole study's end, after follow-up |
| First posted | 2021-03-03 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-05 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Hernia, Ventral
- Hernia, Inguinal
Intervention
- Device: OviTex Reinforced Tissue Matrix
Primary outcomes
what the primary-completion date above is the date OFEarly surgical site occurrences or wound related events
measured occurring within the first 3 months of the ventral or inguinal hernia repair
Early post-operative complications
measured occurring within the first 3 months of the ventral or inguinal hernia repair.
Permalink · TELA's whole pipeline · Catalyst calendar · Every registered study · What changed